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Abstract
Hazard ratios are often used to evaluate time to event outcomes, but they
may be hard to interpret. A particular issue arise because hazards are typi-
cally estimated conditional on survival, i.e. on left truncated samples. Then,
hazard ratios from conventional models cannot be interpreted as counterfac-
tual hazard ratios that are immediately relevant to individual patients. This
article explores how the hazard ratios from Cox models may differ from hazard
ratios with a causal interpretation. Using summary data from twin studies, I
suggest an approach to learn about the unmeasured heterogeneity in risk of
an outcome, and this information allows us to explore the interpretation and
magnitude of hazard ratios. Under explicit parametric assumptions, I present
a two-step method to obtain hazard ratios that are more relevant to individual
subjects. The strategy relies on untestable assumptions, but may nevertheless
be useful for sensitivity analyses that are relatively easy to interpret.
∗Corresponding author. Email: m.j.stensrud@medisin.uio.no
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1 Introduction
For time to event outcomes, hazard models are convenient because they allow for
straightforward regressions on covariates. Nevertheless, it is well-known that esti-
mates on the hazard scale, e.g. hazard ratios (HRs), are hard to interpret causally
(Robins and Greenland, 1989; Greenland, 1996; Hernán, 2010; Aalen and others ,
2015; Stensrud and others , 2017). A particular issue arise due to left truncation:
An exposure may be introduced at time t0, but hazard estimates at a later time
t > t0 are calculated from subjects alive at t. Hence, at any t > t0 the HRs are de-
rived from left truncated samples, and not from the baseline population. Standard
HR models, e.g. the Cox model, are based on multiplying likelihood functions for
each event time, and thereby they are sequentially calculated from left truncated
samples. Thus, such HRs do not have an immediate relevance for individual subjects
(Robins and Greenland, 1989), even if the subjects are followed from the onset of an
exposure. This issue has been denoted the inbuilt selection bias of the HR (Hernán,
2010), truncation bias (Vansteelandt and others , 2017) or survival bias (Aalen and
others , 2015).
The issue of left truncation is particularly severe if the onset of follow-up
is delayed. In observational studies, exposures are often present before the subjects
are recruited to the study, and the study sample is not necessarily representative
of the pre-exposure population. Even in randomised controlled trials, the same
issue arise when the treatment effect is assessed in individuals at a time t later
than randomisation at t0 (Hernán, 2010; Greenland, 1996; Aalen and others , 2015;
Stensrud and others , 2017; McNamee, 2017). In such scenarios, causal inference is
not straightforward.
Intuitively, individuals who die before t0 are expected to be the more frail ;
the hazard of an event may be heterogeneously distributed across individuals, and
the subjects who died before t0 were expected to have higher average hazard (Vaupel
and others , 1979; Hougaard, 1995; Aalen and others , 2015). In some scenarios we
have a good understanding of the factors that determine the individual risk, and then
we may include these factors as covariates in our model. However, the heterogeneity
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may often be due to unobserved factors, and adjusting for measured factors will
not be sufficient. In such situations, frailty models have been used to account for
the variation in susceptibility to disease (Vaupel and others , 1979; Lancaster, 1979;
Moger and others , 2004; Haugen and others , 2009; Moger and Aalen, 2008; Moger
and others , 2004). The frailty models may be seen as extensions of the Cox model,
allowing for an unknown heterogeneity parameter. Unfortunately, specifying the
parameters of the frailty distribution is not obvious, in particular when analysing
data on independent individuals.
This article suggests an approach to learn about the frailty distribution
using published summary data. After estimating the frailty distribution, it is possi-
ble to explore the causal interpretation of HRs. In particular, I describe a method
to adjust for survival bias in proportional hazards models. The strategy consists
of two steps: 1) a standard Cox proportional hazards model is fitted to obtain a
marginal HR, and 2) this HR is adjusted to account for unmeasured heterogeneity,
using frailty theory. The method relies on strong parametric assumptions, but under
these conditions we may use published summary data from e.g. twin studies to find
the frailty distribution, and thereby obtain frailty adjusted HRs, assuming that the
frailty is shared among identical twins.
I will illustrate that left truncation is an issue in genetic epidemiology, e.g.
Mendelian Randomisation studies (Vansteelandt and others , 2017; Boef and others ,
2015). These studies rely on genetic variants that are carried from conception, but
subjects are often included into these studies in late adulthood. In particular, I will
use published summary data on the relation between mortality and a gene associated
with alcohol consumption to highlight the magnitude of bias.
2 Issues with conditioning on survival.
Before the modeling framework is formally defined, it is helpful to consider trun-
cation bias in a simple causal graph (Figure 1). We are interested in the effect of
a binary exposure X (taking values 0 and 1) on our survival outcome Y . That
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is, we aim to assess how the rate of Y at a time t may differ under (hypothetical)
interventions on X. We observe individuals conditioning on survival until time t1
(Hence the node S in Figure 1). There is an unknown factor U that also influences
the event times.
The graph provides some immediate insights. The truncation bias due to
conditioning on S is described by the non-causal path X → S ← U → Y . Under
the null hypothesis of no causal effect of X on Y , X → Y is absent, i.e. there is
no truncation bias, and standard hypothesis tests are therefore null-calibrated even
if we condition on S. Similarly, if X → S is absent, truncation bias is neither an
issue. This scenario e.g. arise if the exposure effect is delayed such that it does not
influence entry into the study (Vansteelandt and others , 2017). There may also be
particular parameterisations of th data generating mechanism that do not lead to
bias, which e.g. may be derived from additive hazards models (Vansteelandt and
others , 2017).
For predictions per se, causal effects are not always the primary interests,
and the considerations above are not necessarily relevant; indeed, standard models
may sometimes be immediately applicable.
3 Notation and motivation
Similar to Vansteelandt and others (2017), who recently studied survival bias in
the additive hazards framework, let T denote lifetimes, T0 indicate the time of left
truncation and C denotes the censoring time. Let X be a binary exposure, L is a
vector of measured covariates, and U is an unmeasured time-fixed variable which we
also denote the frailty, such that U ⊥ L, X ⊥ U and X ⊥ L. We use superscript
notation for counterfactual outcomes such that TX=x denotes the lifetime if, possibly
contrary to fact, X is set to x. We will assume that event times are generated from
the hazard
hX=x(t|L,U) = h(t|X = x, L, U) = h0(t) exp(βxX + βTl L)U, (1)
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where L is a vector of measured covariates and r(t) = eβx is the counterfactual HR
under X conditional on U and L. Equation (1) is coherent with the classical frailty
model, suggested by e.g. Vaupel and others (1979) and Lancaster (1979). The model
in Equation (1) lends on the untestable assumptions that U is time constant, and
that r(t) is the same for all levels of U . These assumptions allow us to consider r(t)
as a marginalised estimand because
EU(h
X=1(t|L,U))
EU(hX=0(t|L,U)) = r(t). (2)
Such ratios are often considered in the statistics and economics literature individual
hazard rates (Hougaard, 1995; Van den Berg, 2001; Van den Berg and Drepper,
2016).
In a deterministic counterfactual framework individual hazards may not
be interesting per se: At the event time, the individual hazard will be infinity, and
at any other time the hazard will be 0, meaning that the individual HR is either
0 or undefined. Nevertheless, r(t) does have a meaning under the data generating
mechanism in Equation (1), which may be interpreted as a particular stochastic
counterfactual model: Under these particular assumptions, it may be interpreted
as the probability of causation due to X (Robins and Greenland, 1989), which
e.g. seems to be used in compensation issues: Assume that a subject exposed to
an environmental toxin X experienced an event at t, and an insurance company
will give compansation based on the probability that the event was caused by X.
Then, r(t)−1
r(t)
may denote the probability of causation. Intuitively, r(t) is the relative
effect that an individual cares about: It is the rate ratio under the counterfactual
scenarios of being exposed or unexposed. Since U is unknown, r(t) cannot yield
precise information about the absolute increase in hazard or risk.
The frailty model in Equation 1 is compatible with a Cox model with
hazard ratio r? of X only if
r? =
EU(h(t|X = 1, L, U))
EU(h(t|X = 0, L, U)) (3)
is valid for all t. Importantly, under a constant r(t) = r, Equation (3) will only
hold under very special conditions, such as r = 1 or VAR(U) = 0. However, even
if the Cox proportional hazard assumption is valid, there is still no simple relation
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between r? and r(t) (Hernán, 2010). In contrast to r(t), it is therefore hard to
interpret r?, and it is not a counterfactual rate ratio with an immediate relevance
to an individual.
The Cox PH assumption can obviously be assessed from the data during
follow-up, which is clearly an advantage of the method. Before the onset of follow-
up (T0), however, we have no way to justify the proportional hazards assumption.
Hence, not only the frailty model, but also the standard Cox model will rely on
untestable assumptions in left truncated samples. We will hereby assume that data
are generated from models in which r(t) = r for all t, which is analogous to the
proportional hazards assumption of the Cox model.
3.1 Study populations
Assume that we got a random sample S1 of subjects 1, 2, ..., n from a population P
with event times generated by Equation (1). We observe left truncated lifetimes,
i.e. all study subjects got T > t0, where t0 is the time of left truncation. The event
times may be censored at C such that for each individual we observe V = min(T,C),
and we assume independent censoring. For the ease of presentation, there are no
measured covariates L in the following considerations, but the approach is valid
when L is present. Based on the observed event times we aim to estimate r. The
frailty U is unmeasured, and left truncation is obviously an issue (Vansteelandt and
others , 2017).
Assume also that we got summary results from another random sample
S2 of P , consisting of pairs of individuals sharing the same U , and each subject is
unexposed to X. If U was solely determined by genetic factors, S2 could e.g. be
a population of monozygotic twin pairs. This sample only contains information on
whether each subject survived until T0. In practice, these data could e.g. be derived
from a twin birth registry. Suppose also that we know the parametric distribution
of U . This information may allow us to estimate r(t) in a left truncated sample.
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4 Learning the frailty distribution from the data
Let U be a random variable with E(U) = 1, i.e. any standardised (frailty) dis-
tribution with a finite mean. Let S(t) = P(T > t), i.e. the survival probability
unconditional on U and X. The cumulative baseline hazard is H0(t) =
∫ t
o
h0(t)dt.
Let Ti and Tj denote the time of event for individuals i and j who are monozygotic
co-twins. Assuming everybody is unexposed, and let the twin recurrence risk at
time t be TRR(t), which is the relative risk of surviving until time t, given a co-twin
lived longer than t,
TRR(t) =
P(TX=0i > t|TX=0j > t)
P(TX=0i > t)
=
P(TX=0i > t, TX=0j > t)
P(TX=0i > t)2
because P(TX=0i > t) = P(T
X=0
j > t)
=
E[S(tX=0|U)2]
S(tX=0)2
=
E[e−2H0(t)U ]
E[e−H0(t)U ]2
=
L[2H0(t)]
L[H0(t)]2
, (4)
where L denotes the Laplace transform of U .
4.1 Analytic results for the power variance function distribu-
tions
Assume that the distribution of U belongs to the large class of power variance func-
tion (PVF) distributions, which e.g. includes the gamma distribution, the inverse
Gaussian distribution, the (compound) and the Poisson distribution. The PVF
family also includes the Hougaard distributions(Hougaard, 2012) that are contin-
uous and unimodal and cover the inverse Gaussian distribution as a special case.
Similar to Aalen and others (2008), we consider PVF distributions with E(U) = 1,
and we express the expected value, variance and Laplace transform of the PVF
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family as
mρ
ν
= 1,
VAR(U) =
(m+ 1)
ν
,
L(c|ν,m) = e− νm (1−( νν+c )m), (5)
where ν > 0, m > −1 and mρ > 0. The survival function under a PVF distribution
is
S(tX=0) = E(e−H0(t)U)
= L(H0(t)|ν,m)
= e
− ν
m
(
1−
(
ν
ν+H0(t)
)m)
. (6)
We will use Equations (5) and (6) to find VAR(U) under a particular PVF distri-
bution.
4.1.1 Calculations for the gamma distribution
To illustrate, we consider the gamma distribution, which is probably the most fre-
quently used distribution in frailty theory. The gamma distribution is mathemati-
cally tractable, and it may be theoretically appealing because the heterogeneity of
frailty distributions converges to a gamma distribution among survivors (Abbring
and Van Den Berg, 2007). However, assuming a gamma distributed U at t0 can typ-
ically not be tested, and we must heuristically justify the distribution, e.g. because
we believe that U consists of a sum of factors, making it continuous in the popu-
lation. Using the notation in Equations (5) and (6), the gamma distribution arises
when ρ→∞ and m→ 0 such that ρm→ η > 0, where η. since E(U) = η
ν
= 1, the
gamma frailty reduces to a one parameter distribution, and the Laplace transform
becomes
L(c|ν) =
(
ν
ν + c
)ν
. (7)
We may simplify Equation (6) to
S(tX=0) = E(e−H0(t)U) = L(H0(t)|ν) =
(
ν
ν +H0(t)
)ν
, (8)
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and from Equation (7) we simplify TRR(t) to
TRR(t) =
(
ν
ν+2H0(t)
)ν
S(tX=0)2
, (9)
We use Equation (8) to express H0(t) as a function of S(t|X = 0) and ν
H0(t) =
ν(1− S(tX=0) 1ν )
S(tX=0)
1
ν
. (10)
Finally, we replace H0(t) in Equation (9) by the right side of Equation (10), and to
find ν we can numerically solve
S(tX=0)2TRR(t)−
 1
1 + 2
(
1−S(tX=0) 1ν
S(tX=0)
1
ν
)

ν
= 0
(11)
for any time point t = t1. When ν is derived, we are able to specify the variance
of a gamma distributed U . The same logic can be used for other PVF distribu-
tions (see the Appendix for R scripts that implement these methods numerically).
We consider a counterfactual population of unexposed individuals, and this popula-
tion is generally unobserved. In practice, we will estimate the TRR from observed
quantities.
In the next section, I will describe how the information on U can be used
to obtain estimates of HRs r with a causal interpretation. This requires an estimate
of the marginal HR among survivors at a specific time t1, which is approximated by
a Cox proportional hazards estimate in an interval [t1, t1 + δ].
4.2 Using the marginal HR to estimate the causal HR
We continue to study the PVF family. Assume that our data are generated by a
proportional hazards model as in Equation (1), and let rmar(t) denote the marginal
HR among survivors at time t. Let r denote the (constant) causal HR conditional
on U , such that (Aalen and others , 2008)
rmar(t) = r
(
1 + H0(t)
ν
1 + rH0(t)
ν
)m+1
, (12)
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which means that
rmar(t)
1
m+1
(
1 +
H0(t)r
ν
)
= r
1
m+1
(
1 +
H0(t)
ν
)
. (13)
Assume that ν is derived by the approach in Section 4.1, e.g. using twin data. The
marginal HR at a particular time t1 is approximately derived from a Cox propor-
tional hazards model in an interval [t1, t1 + δ]. For the gamma distribution, m→ 0,
and we find r analytically by solving
r = rmar(t)
(
1 +
H0(t)
ν
− H0(t)rmar(t)
ν
)−1
(14)
for any time point t = t1, where we use Equation (10) to find H0(t). For the
inverse Gaussian distribution, m = −0.5, and we obtain r analytically by solving a
quadratic equation
r2
(
1 +
H0(t)
ν
)
− r
(
rmar(t)
2H0(t)
ν
)
− rmar(t)2 = 0.
For other distributions in the PVF class, we may solve Equation (13) with respect
to r numerically. Confidence intervals of r can be found numerically, as suggested
in Appendix A. In Appendix B, a simulation study of plausible scenarios was per-
formed, in which the adjusted 95% confidence intervals obtained approximately 95%
coverage of the true r in all scenarios.
In applied settings, we may expect a slight bias towards a null effect because
because the marginal HR at t1 is approximated by a Cox proportional hazards
estimate in [t1, t1 + δ], as suggested in Section 4.1.1. This means that we adjust for
the impact of U until t1, but we do not adjust for the effect of U during follow up
[t1, t1 + δ]. In the simulations in Appendix B, t1 = 50 was much larger than δ = 2,
and the bias was negligible.
Nevertheless, McNamee (2017) has recently suggested a heuristic approach
to deal with this model misspecification if the frailty is gamma distributed: Assume
that we follow a population from t0, and let tmedian be the median of all event
times in the population. Under a gamma distributed frailty, replacing t by tmedian
in Equation (14), will yield adequate estimates of r. This approach was shown to
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perform satisfactory in simulations (McNamee, 2017). Hence, if we follow subjects
from t0, we may plug in frailty estimates from twin data into the expression suggested
by McNamee (2017), and thereby explore the truncation bias, e.g. in RCTs.
4.3 When is survival bias an issue?
The magnitude of survival bias varies with (i) time, (ii) the size of the observed
TRR and (iii) the parameterisation of the frailty distribution. We shall consider
some scenarios, using the derivations in Sections 4-4.2.
First, Equation (12) shows that the bias increases with t. In particular,
when t → ∞, we have that rmar(t) → r−m. For the gamma distribution, m →
0, and rmar(t) → 1. Hence, the marginal HR will be attenuated towards a null-
effect (Van den Berg, 2001). For some conditions, it may be that only a fraction
of the population is susceptible, e.g. for a particular disease. In these scenarios,
the compound Poisson model is convenient, because it allows for a non-susceptible
fraction. For the compound Poisson distribution, m > 0, and
lim
t→∞
rmar(t) = r
−m < 1 if r > 1
lim
t→∞
rmar(t) = r
−m > 1 if r < 1,
which means that we eventually will observe rmar in the opposite direction of r. This
may have important implications: The marginal HR is not only a biased estimate
of r, but it may also be invalid for hypothesis testing of an effect of r. Even though
this relation is well-known in the methodological literature (Robins and Greenland,
1989; Van den Berg, 2001), it may be under-appreciated in the applied literature
(Burgess, 2015). In Figure 2, the relation between the unconditional HR and left
truncation is displayed for some PVF distributions with variance equal to 1. In all
scenarios the conditional HR is 1.2, but the unadjusted HR declines a function of
the population fraction lost to left truncation.
Second, a large TRR(t) yields a large variation in risk between individuals
(Valberg and others , 2017). Intuitively, we may also think that a large variation
in risk leads to larger survival bias. To perform a numerical evaluation of the bias,
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let the population be assessed at time t1 such that S(t1) = 0.9. In Figure 3, we
display r as a function of the TRR(t1) when rmar(t1) = 1.2. For a fixed rmar(t1),
the conditional r increases TRR(t1).
5 Extension to IV estimates
Instrumental variable (IV) approaches may be useful to identify causal relations.
To find the effect of an exposure on an outcome, these techniques rely on an ad-
ditional variable, the instrument. Let L be measured covariates, and let U be a
possibly unmeasured confounder. Given L, an instrument must satisfy the following
assumptions to obtain unbiased effect estimates:
• The instrument G is associated with the exposure A, i.e. G 6⊥ A|L.
• The only path leading from G to the outcome Y goes through the exposure,
G ⊥ Y |A,U, L.
• G is independent of any unmeasured factor U that confounds the exposure-
outcome relation G ⊥ U |L.
For more information on the IV assumptions, see e.g. Didelez and Sheehan (2007).
In the biomedical literature, the number of analyses based on IVs are increasing.
Mendelian Randomisation (MR) studies are particularly popular, and such analyses
rely on genetic variants as instruments. There is, however, a temporal aspect of MR
studies. The genetic variants are allocated at conception (t = 0), but the follow-up
starts in adult life. Hence, survival bias is potentially a major issue because (i) there
is often a large time-lag between perceived randomization at t0 and follow-up, and
(ii) MR holds the promise to reveal causal effects.
A causal structure of an IV setting with survival outcomes is shown in
Figure 4. Here, S is survival until time t1. Until now we have considered a simple
binary exposure, but we will hereby let the exposure A(t) be a time-varying contin-
uous variable expressed as a function of the binary instrument G and the unknown
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component U . Let the data generating mechanism of A(t) be
A(t) = b0(t) + bgG+ b
T
l L+ f(U) + e(t), (15)
where f(U) is a random variable such that E(f(U |G)) = E(f(U)), L denotes the
measured covariates assuming that L ⊥ G and L ⊥ U , and e(t) is a residual error
independent of U which we do not specify further. If E(f(U)) = z, we substitute
b0(t) with b∗0(t) = b0(t) + z and f(U) by f ∗(U) = f(U)− z, such that E(f ∗(U)) = 0.
In Equation (15) we assume that bg is time constant for each subject, which is not
trivial to justify in practice (see e.g. Abbring and Heckman (2007) who discuss this
in an economics context).
Tchetgen and others (2015) suggested a proportional hazards strategy for
IV analyses, which is only valid for rare outcomes due to the non-collapsibility of
the hazard ratio. By modelling the relation between U and survivial (T ), I will
suggest a proportional hazards approach that is not only valid under the rare events
assumptions. Similar to Tchetgen and others (2015), I will consider a proportional
hazards model for the outcome Y ,
h(t|U,A(t), G) = h(t|U,A(t))
= h0(t)e
βaA(t)+βTl Lψ(U), (16)
where ψ(U) is a function of U independent of A. In Equation (16), the first line is
justified by the graph in Figure 4, and the second line displays the assumed causal
hazard function. Hence, βa denotes the causal effect of A(t) on Y conditional on U ,
which is our estimand. Different from Tchetgen and others (2015), we allow A(t) be
time-varying, but we restrict ψ(U) to be time-constant.
To estimate βa, we must rely on information about G and U , and we will
use the results derived in Section 4.1. It may indeed be unappealing that this IV
analysis will require explicit assumptions about U , because the motivation for using
an instrument is to avoid modeling U . Nevertheless, in the Mendelian randomization
context, one may also argue that the IV assumptions are not met, because G 6⊥ U
under left truncation. To deal with this issue, I will model the relation between U
and survival T , but I will still be agnostic about the relation U → A.
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5.1 Causal estimates in Mendelian randomisation studies.
We aim to estimate βa. Writing out Equation (16) gives
h(t|U,A(t), G) = h0(t)eβa(b0(t)+bgg+bvV+f(U)+e(t))+βTl Lψ(U). (17)
We introduce the parameter U? such that U? = eβaf(U)ψ(U). Similar to Section 4.1,
we assume that U? has a distribution with finite mean in the population, and we
assume that U? is standardised such that E(U?) = 1. Inserting U? in Equation (17),
we obtain
h(t|U,A(t), G) = h0(t)eβa(b0(t)+bvV+bgg+e(t))+βTl LU?. (18)
Let g1 and g2 be two variants of the instrument G. We can then consider the genetic
HR
HRG =
h(t|U?, G = g1)
h(t|U?, G = g2)
= eβabg(g1−g2).
(19)
We can find an estimate bˆg of bg, e.g. by fitting a linear regression based on Equation
(15). Furthermore, HRG can be estimated with the strategy in Section 4 such that
βˆa =
log[HˆRG]
bˆg(g1 − g2)
. (20)
In contrast to Tchetgen and others (2015), in Equation (20) it is not assumed that
S(t|U,A(t), G) ≈ 1. Tchetgen and others (2015) required the rare events assump-
tion, because they used standard Cox proportional hazards regression to find the
marginal HR under a data generating mechanism similar to Equation (16). Hence,
they assumed that the causal effect of the exposure conditional on U is proportional
on the hazard scale, but they fitted a Cox proportional hazards model unconditional
on U . Due to the non-collapsibility of the HR, the unconditional model is approxi-
mately correct only if the event is rare. In this article, we do use the estimates from
a (mis-specified) marginal proportional hazards model in an interval [t1, t1 + δ] as
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an approximation to rmar(t1). However, we do not require that the true, marginal
HR can be correctly estimated by a Cox model at other times t, and we therefore
do not need the rare events assumption.
Until now the instrument G has been considered to be binary. A binary G
may be reasonable when the instrument is a single gene, which initially was the stan-
dard approach for MR analyses. Today, however, most analysts use instruments that
are combinations of multiple variants, usually quantified in a continuous genetic risk
score (Burgess and Thompson, 2013). This approach will often increase the power
of the study, but it also requires all the single variants to satisfy the IV assumptions.
Our approach is readily applicable to continuous instruments. Specifically, we then
consider G to be a continuous variable, and Equation (15) thereby require G to have
an additive effect on the Exposure A(t). The remaining derivations in Section 5 will
all be valid for both a continuous and a binary G.
6 An illustrative example
6.1 The effect of alcohol on all-cause mortality
Almeida and others (2015) assessed the impact of alcohol consumption on all-cause
mortality in a sample with 3496 old men (aged 70-89 years at baseline). To do this,
they used genetic information on the Alcohol Dehydrogenase 1B (ADH1B) gene. A
mutation in the gene, which was carried by 225 of the subjects, leads to abnormal
metabolism of ethanol, and carriers experience an unpleasant flushing while drinking.
It is well-known that carriers consume less alcohol (Holmes and others , 2014), and
their reduced consumption is thought to be independent of confounding factors.
Following Almeida and others (2015), we will consider the effect of (ADH1B)
gene on all-cause mortality, and not the effect of alcohol per se. At baseline there
should not be confounders that affects all-cause mortality and carrying ADH1B.
However, in a left truncated sample the mortality HR between carriers and non-
carriers of the genetic variant ADH1B (now, considered to be the exposure X in
15
Figure 1) is not easy to interpret; at least it cannot be interpreted as the counter-
factual rate ratio of carrying vs not carrying the ADH1B in a subject. To illustrate,
we consider the marginal HR
rAlmeida = 0.68 [0.54, 0.87]
in carriers of the mutation, which was derived by Almeida and others (2014). With
the frailty methods, we may explore how this marginal estimate may deviate from
a counterfactual rate ratio under explicitly defined model assumptions.
First, we consider the age of 75 years, which is approximately the mean age
at baseline in the study by Almeida and others (2014), such that rmar(75) = rAlmeida.
Analyses of a Scandinavian registry of 9272 male twins suggest that the relative
probability of surviving 75 years, given a co-twin survived 75 years, is 1.27 in men
(Hjelmborg and others , 2006). Therefore we let ˆTRR(75) = 1.27, assuming that the
probability of surviving until 75 years is shared among monozygotic twins. Here,
we should ideally have assessed the TRR(75) in a (counterfactual) population of
non-carriers of the ADH1B mutation, but we used the whole population as a crude
estimate (in Scandinavians less than 4% carry the mutation, which is even rarer
than in Australians (Linneberg and others , 2010)).
According to Australian cohort life tables of subjects, 0.56 of Australian
men born 1931-1936 survive until age 75 years (Rowland, 1997). We assume a
gamma distribution of U ; heuristically we then believe that everybody has a hazard
larger than 0 for dying at any time, and the individual hazards vary continously in
the population. Intuitively, these hazards will arise due to a combination of several
unmeasured factors denoted U . We will use the values TRR(75) = 1.27 [1.20, 1.34],
S(75) = 0.56 and rmar(75) = 0.68 [0.54, 0.87] to estimate the causal HR conditional
on U . To highlight the magnitude of bias due to U , we first assume that TRR(75)
and S(75) are true values without uncertainty, and we numerically solve Equation
(11) to find ν = 0.846. Then, we use Equation (14) to estimate the causal HR by
rˆ = rmar(75)
(
1 +
H0(75)
0.846
− H0(75)rmar(75)
0.846
)−1
= 0.52 [0.37, 0.77].
The 95% confidence interval is simply derived by plugging in the confidence limits
of rmar(75) into Equation (14), and these estimates are valid due to the monotonic
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relation between r and rmar. We thereby assume that TRR(75) and S(75) are the
true values in the population.
The frailty analysis suggests that rmar(75) is a conservative estimate of r.
To derive this estimate, we have required that a weighted average of r(t) before
follow up is equal to the the causal HR during follow up. Allthough this is a
straight-forward extension of the standard Cox proportional hazards assumption,
it is an untestable assumption, and interpreting rˆ causally requires very strong
structural assumptions. Rather, rˆ gives us an impression on how the crude HRs
from Cox models may differ substantially from HRs that actually have a causal
interpretation.
We may also obtain estimates of r by assuming other parameterisations
of U . In Table 1, we have shown results for 4 PVF distributions, using plug-in
confidence intervals (95% CI plug-in). In this example, the results are robust to
the parameterisation of U . Intuitively, this is due to the relatively small TRR(t1).
However, this robustness does not necessarily apply to other scenarios (Stensrud
and others , 2017), e.g. for larger TRR(t1), as also seen in Figure 3.
In applications, it is not sufficient to account for the uncertainty in rmar.
We must also consider the uncertainty in the other summary estimates that are used,
i.e. TRR(t1) and S(t1). A numeric approach to derive such confidence intervals is
described in Appendix A. We use this approach to account for the uncertainty
in TRR(75) = 1.27 [1.20, 1.34] in the 4 frailty distributions, and these results are
displayed in Table 1 (95% CI numeric). In this example, these estimates are similar
to the plug-in estimates.
7 Discussion
Conventional HRs are difficult to interpret (Stensrud and others , 2017; Aalen and
others , 2015; Hernán, 2010; Robins and Greenland, 1989). This article explores the
causal understanding of HRs. By modelling the unobserved heterogeneity in disease
risk, conventional hazard ratios are compared to conditional HRs with a causal
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Distribution of U rˆ[t1,t1+δ] 95% CI plug-in 95% CI numeric
Gamma 0.52 [0.37, 0.77] [0.35, 0.74]
Inverse Gaussian 0.53 [0.37, 0.79] [0.36, 0.77]
Hougaard (m = −0.125) 0.52 [0.37, 0.77] [0.35, 0.77]
Compound Poisson (10% nonsusceptible) 0.52 [0.38, 0.77] [0.36, 0.76]
Table 1: Estimates of the causal hazard ratio of the ADH1B variant on all-cause
mortality, conditional on the frailty. Results from 4 different PVF distributions are
displayed.
interpretation. This approach may be useful for sensitivity analysis, e.g. to explore
how a HR from Cox model may approximately be relevant to individual patients.
More generally, this article highlights a link between frailty models in sur-
vival analysis and causal inference (Stensrud and others , 2017): Interpreting esti-
mates from Cox regressions may be challenging, e.g. due to non-collapsibility (Mar-
tinussen and Vansteelandt, 2013) and left truncation. However, by using frailty
models with strong parametric assumptions, we find estimates that are easier to in-
terpret: We identify the effect of the exposure conditional on the unobserved variable
U , and intuitively this is the effect of the exposure on the individual level.
When measured covariates are able to explain most of the heterogeneity in
risk, the frailty approach may be less desirable than alternative approaches, in which
covariates are included in the model. For many conditions, however, unmeasured
factors may have considerable impact. In such situations, the frailty approach seems
to be particularly attractive, e.g. in sensitivity analyses.
I have suggested an approach that only relies on summary data of the risk
heterogeneity, e.g. derived from twin registries. This is desirable, because individual
level data are often unavailable. However, If we got access to individual level data,
it may be better to perform a joint analysis (see e.g. Van den Berg (2001)).
By using twin data, I attempt to adjust for heterogeneity due to (unmea-
sured) genetic factors and shared environment. Using data from monozygotic twins
is desirable, because such co-twins are genetically identical and expected to share
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several environmental factors. Nevertheless, non-shared environmental factors will
not be captured unless they are included as measured covariates L. If such factors
are unmeasured and have large (multiplicative) effect on the hazard function, we
may underestimate the magnitude of survival bias. Furthermore, assuming a time-
constant U is simplistic, in particular because co-twins may influence each other over
time, e.g. in health seeking behaviour. We have also implicitly assumed that twins
are representative of the general population. In particular, unmeasured factors that
influence survival until follow-up at t1 should be similarly distributed in twins as
in the general population. Recently, it has been suggested that monozygotic twins
live longer than the general population, but the difference was found to be modest
(Sharrow and Anderson, 2016).
This article has considered proportional hazards models with time to death
as outcome. The approach can also be used to other time to event outcomes. e.g.
time to progression of a disease. For many diseases we will expect the survival bias
to be larger (Stensrud and others , 2017); we have shown that a larger variance in the
unobserved heterogeneity yields a larger survival bias, and the familial clustering of
several diseases is considerably larger than the familial clustering of longevity. For
such outcomes, we may deal with survival bias by introducing correlated unknown
factors (U1 and U2) that influence the time-to-event, respectively, and thereafter use
theory for separate, correlated frailty variables (see e.g. Aalen and others (2008)
chapter 6.6).
The survival bias is a particular issue in MR studies, due to the long time
lag between randomisation and follow up (Boef and others , 2015; Martinussen and
others , 2017). Interpreting IV estimates for time-to-event outcomes is not straight-
forward (Burgess, 2015), but such methods have recently been developed, under ex-
plicitly defined assumptions. In particular, estimates from the Aalen additive model
do not suffer from survival bias under some explicit parameterisations of U (Tchetgen
and others , 2015; Martinussen and others , 2016; Li and others , 2015). MacKenzie
and others (2014) considered a Cox proportional hazards model with additive un-
observed confounding, but it relies on some unrealistic assumptions (Tchetgen and
others , 2015). Very recently, estimation under a IV structural Cox model for the
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treatment effect of the treated was suggested (Martinussen and others , 2017). This
approach allows us to estimate a causal HR when subjects are follow from t0, but it
may still be hard to handle left truncated samples.
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A Derivation of confidence intervals
To derive estimates of the causal hazard ratio rcau, we need to consider three es-
timates with uncertainty: 1) The marginal HR (rmar), 2) The familial risk (twin
recurrence risk) at time t1 (TRR(t1)), and 3) The probability of surviving until
t1 (S(t1)). We assume that these estimates are derived from independent sources.
Then, it is simple to derive confidence intervals ofHRcau, using a numeric evaluation.
Since rˆmar is derived from a Cox model, we have that log(rˆmar) is approximately
normally distributed. Similarly, ˆTRR(t1) is estimated as a relative risk, and hence
log( ˆTRR(t1)) is approximately normally distributed. By considering survival until
t1 as a sample proportion, Sˆ(t1) is approximately normally distributed for large n
without transformation. We can use this to find a numeric confidence interval, based
on n simulated estimates
1. Let the estimate of rmar be rˆmar with 95% confidence interval [rˆmar,min, rˆmar,max].
Then,
log(rˆmar)∼˙N
(
log(rˆmar),
log(rˆmar)− log(rˆmar,min)
Φ−1(0.975)
)
,
where Φ−1(c) is the inverse cumulative standard normal distribution. Hence,
for each i in 1, 2, ..., n we draw log(rˆmar,i) from this distribution.
2. Let the estimate of TRR(t1) be ˆTRR(t1) 95% CI: [ ˆTRR(t1)min, ˆTRR(t1)max].
Then,
log( ˆTRR(t1))∼˙N
(
log( ˆTRR(t1)),
log( ˆTRR(t1))− log( ˆTRR(t1)min)
Φ−1(0.975)
)
.
Hence, for each i in 1, 2, ..., n we draw log( ˆTRR(t1)i) from this distribution.
3. Let the estimate of S(t1) be Sˆ(t1) 95% CI: [Sˆ(t1)min, Sˆ(t1)max], e.g. derived
from Greenwood’s formula. Since the 95% CI is on the form Sˆ(t1)±zα/2se(Sˆ(t1))
We draw Sˆ(t1)i ∼ N
(
Sˆ(t1),
Sˆ(t1)−Sˆ(t1)min
Φ−1(0.975)
)
.
4. Finally, for each i in 1, 2, ..., n we obtain an estimate rcau,i by plugging the
estimates in 1.-3. into the algorithm described in the main text. A (1 − α)
confidence interval of rcau,i is found by using the α2 and
1−α
2
quantiles of the
estimates.
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B Simulations to verify the approach
A simulation algorithm was derived to check the validity of the causal estimates
in Section 4.1. This algorithm consists of 3 steps, and the R code to implement
the approach is attached. Below is a brief description of the approach in natural
language.
Step 1. Simulate survival times and find the marginal HR.
• Select n1 unexposed subjects. Each i in 1, 2, ..., n1 is characterised by an
individual frailty Ui, and we randomly draw the variable Ui ∼ Gamma(mean =
1,VAR = ν).
• Similarily, we select n2 exposed individuals. For each j in 1, 2, ..., n2 we ran-
domly draw Uj ∼ Gamma(1, ν).
• Let the causal hazard ratio of the exposure X conditional on U be r.
• Assume that the baseline hazard rate is constant, h0(t) = h. To obtain survival
times for each i, we first draw Wi ∼ Uniform[0, 1]. Then we find the survival
time
Si =
log(W )
hUi
,
as suggested by Bender and others (2005).
• Similarly, for each j we draw Wj ∼ Uniform[0, 1], and we find the survival
time
Sj =
log(W )
rhUj
.
• Assume follow up starts at t = t1.
• We then select the sets of individuals L1 such that i ∈ Li iff Si > t1, and L2
such that j ∈ Lj iff Sj > t1.
• To derive the marginal HR, we fit a Cox proportional hazards model to the
subjects in L1 and L2, using exposure X as the only covariate.
27
Step 2. Simulate twin recurrence risks.
• To estimate the twin recurrence risk, select n3 unexposed twin pairs. This
sample is independent of the sample in Step 1.
• For each twin pair m in 1, 2, ..., n3, we randomly draw the shared Um ∼
Gamma(1, ν).
• For each twin pair, we selected a random co-twin m1. We then find the overall
risk of surviving until t1,
S(tX=0 > t1) =
1
n3
n3∑
1
I(Sm1 > t1),
where I(Si > t1) is an indicator function taking value 1 if Si > t1 and 0
otherwise.
• Let L3 denote the set of survivors such that m1 ∈ L3 iff Sm1 > t1. Denote the
number of subjects in L3 as nL3 . Then, we find the conditional probability of
survival in m2 given m1 survived
S(tX=0m2 > t1|tX=0m1 > t1) =
1
nL3
nL3∑
1
I(Sm2 > t1).
• We estimate the twin recurrence risk
S(tX=0m2 > t1|tX=0m1 > t1)
S(tX=0m2 > t1)
.
The standard errors are e.g. found using Wald estimators for relative risks.
Step 3. Simulate survival until time t1.
• To make the simulations realistic, let the life-time risk of disease be selected
from a new sample.
• Select n4 unexposed subjects.
• For each subject i in 1, 2, ..., n4, we randomly draw the Ui ∼ Gamma(1, ν).
• Similar to Step 1 we find Si for each i. Then we simply estimate Pr(Si > t1)
with standard confidence intervals, assuming a normal distribution.
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Step 4. Simulate survival until time t1.
• Based on the confidence intervals derived from Part 1-3, we can find the con-
fidence interval of the causal hazard ratio numerically. To do this, we use the
strategy suggested in Appendix A.
B.1 Validation of particular scenarios
The simulation algorithm can be used to check the approach under particular scenar-
ios. To illustrate, let the effect of the exposure X conditional on U be a hazard ratio
rcau(t) = 0.80. Furthermore, let the distribution of U be characterized by mean= 1
and ν = 1
9
. The basic hazard rate is set to h0(t) = 0.002. Using the derivations
in Section 4, we find that the exact value TRR(t1) = 1.029 and S(tX=01 ) = 0.931).
This scenario was simulated 500 times. In each simulation, 104 unexposed subjects
and 104 exposed subjects were included. Follow-up was initiated at t1 = 50, i.e.
only those who survived until the age of 50 were included. The duration of follow
up was 1 year. This allowed for the calculation of marginal HR from a Cox propor-
tional hazards model. The marginal estimates (rˆmar(t1)) were biased towards the
null; Only 31.2% of the marginal 95% confidence intervals covered rcau. To obtain
adjusted estimates, we used simulated data from an independent sample of 104 twin
pairs, in which the TRR(50) was estimated. We also used independent sample of
104 subjects to estimate S(50) to obtain frailty adjusted estimates, and confidence
intervals were found by the approach in Appendix A. These adjusted estimates were
better calibrated; 94.8 % of the adjusted 95% confidence intervals covered rcau. A
summary of the simulations is found in Table B.1 (Scenario 1).
Similarly, two more extreme scenarios were also simulated (Table B.1, Sce-
nario 2 and Scenario 3). In these scenarios, the same number of subjects were
included for estimating rˆmar(t1), TRR(t1) and S(t1) as in Scenario 1. However, dif-
ferent values for rcau, h0(t) and ν were introduced. In these scenarios, the coverage
of the confidence intervals for rˆmar(t1) were close to 0, but the adjusted estimates
showed coverage approximately 95%.
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In all scenarios, the adjusted estimates (rˆadjusted(t1) in Table B.1) are closer
to the true value.
Scenario 1 2 3
Input
Simulations 500 500 500
rcau 0.80 0.70 0.70
h0 0.002 0.003 0.030
ν 1
9
1
15
1
5
t1 50 50 50
Output
Median rˆmar(t1) 0.89 0.89 1.01
Median rˆadjusted(t1) 0.81 0.70 0.71
Coverage 95% CI mar 0.406 0.002 0
Coverage 95% CI adjusted 0.964 0.962 0.950
Table B.1: Summary of 3 simulated scenarios.
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B.2 Calculation of IV estimates
In many MR analyses, only the association between the instrument and the outcome
is reported (Burgess, 2015). This may be due to the fact that deriving and causally
interpreting IV estimates require some caution (VanderWeele and others , 2014), in
particular for time to event outcomes (Burgess, 2015; Tchetgen and others , 2015).
Among other things, the genetic instruments are fixed throughout life, whereas
the exposure may be a dynamic process. Indeed, we may interpret the results in
Section 6.1 as an MR analysis, in which only the association between ADH1B (the
instrument for alcohol) and all-cause mortality is included.
βˆa =
log[HˆRcau(75)]
bg,[t1,t1+δ](g1 − g2)
=
log(0.52)
−0.172 ∗ 14.2(1− 0)
= 0.27 [0.11, 0.41]
We may interpret eβˆa = 1.31 [1.11, 1.50] as the estimated HR under an intervention
in which the alcohol consumption was increased by 1 unit per week throughout life.
If HRcau(75) was replaced by rmar(75) in Equation (20), we would yield a HR of
1.17 [1.06, 1.29].
This crude example suggests that the magnitude of survival bias may be
considerable, in particular when there is an extreme selection of the oldest old. These
particular IV results, however, should be interpreted with some caution. I have used
summary data from three different sources to obtain the estimates. This illustrates
how the procedure can be performed simply by using summary data. However, the
results rely on the validity of each source of data. In particular, I have used data
from monozygotic twins in Scandinavia to derive the TRR, whereas the study was
performed in Australia. The effect of alcohol on mortality may also be non-linear in
real life, e.g. that heavy drinking has a larger effect on mortality. Nevertheless, this
example illustrates how the frailty approach can be applied to explore bias in IV
settings. If specific estimates of TRR(t1) and S(t1) are unavailable, the suggested
approach can still be performed as a sensitivity analysis: Applied researchers can
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check the sensitivity to survival bias in their analysis by fitting frailty distributions
with various values of TRR(t1) and S(t1).
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C Appendix: R code
######## Functions ########################
#Find V implements the d e r i v a t i o n s in Sec t ion 2.2 f o r the
Gamma d i s t r i b u t i o n
#In s e r t FRR ( f am i l i a l recurrence r i s k or s i b l i n g recurrence
r i s k ) ,
#the cumula t ive s u r v i v a l S , the observed hazard r a t i o r_obs
i s denoted observedHR
f indV <− function (FRR, S , observedHR=1.23 , from1=1e−30, to1=20,
l en =30, r r =2.10 , plotAndPrint=F, nonStandard=F, printV=F) {
sequence <− seq ( from=from1 , to=to1 , length . out=len )
r i gh tS i d e <− FRR∗S^2
tryCatch ({
v <− uniroot ( combinedFRRS , S=S , r i gh tS i d e=r ightS ide ,
i n t e r v a l=c (0 , to1 ) )$ root [ 1 ]
} , warning = function (war ) {
print ( "warning ! ! ! " )
v <− NA
} , e r r o r = function ( e r r ) {
print ( " e r r o r ! ! ! " )
print ( e r r )
v <− NA
}
)
i f ( printV ) {
print ( v )
}
A <− v∗(1−S^(1/v ) )/S^(1/v )
varZ <− 1/v
causa lRi skRat io <− returnCausa lRisk (HRobs=observedHR , A=A,
v=v)
i f ( plotAndPrint==T){
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plot ( r i gh tS ide−output~sequence , yl im=c (min(0 ,min(
r i gh tS ide−output ) ) ,max( r i gh tS ide−output ) ) , type = " l "
, xlab=" value ␣ o f ␣v" , ylab="S^2∗FRR−output" )
abline ( a=0,b=0,col=1, l t y =2)
print (paste ( "The␣ var i ance ␣ value ␣ i s : ␣" ,1/sequence [ index ] ,
" , ␣with␣ d i f f e r e n c e " , r i gh tS ide−output [ index ] ) )
print (c ( sequence [ index ] ,A, r i skRat io , causa lRi skRat io ) )
}
return ( causa lRi skRat io )
}
#combinedFRRS re turns expre s s i on (10)
combinedFRRS <− function (v , S , r i gh tS i d e ) {
denominator <− 1 + 2∗(1−S^(1/v ) )/S^(1/v )
return ( (1/denominator )^v − r i gh tS i d e )
}
#findVgenera l ex tends findV to s e v e r a l f unc t i on s o f the PVF
fami ly , i . e . the Inver se Gaussian , the Compound Poisson
and the Hougaard Family o f d i s t r i b u t i o n s
f indVgenera l <− function (FRR, S , observedHR=1.23 , from1=1e−6,
to1=100 , l en =20000 , invGaus=F, gamDist=F, comPois=F, Hougaard
=F, nonSuscep=0.01 ,mHougaard=−0.25 , r r =2.10 , plotAndPrint=F
) {
sequence1 <− seq ( from=from1 , to=to1 , length . out=len )
i f ( invGaus ) {
m = −0.5
p <− sequence1/m
sequence <− cbind ( sequence1 , p , rep (m, length ( sequence1 ) ) )
}
i f ( comPois ) {
p = −log ( nonSuscep )
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m <− sequence1/p
sequence <− cbind ( sequence1 , rep (p , length ( sequence1 ) ) , m
)
}
i f ( gamDist ) {
p = 1e13 ; m=1/p
sequence <− cbind ( sequence1 , rep (p , length ( sequence1 ) ) , rep
(m, length ( sequence1 ) ) )
}
i f (Hougaard ) {
m = mHougaard
p <− sequence1/m
sequence <− cbind ( sequence1 , p , rep (m, length ( sequence1 ) ) )
}
As <− apply ( sequence , 1 , f indAgenera l , S=S)
vpmA <− cbind ( sequence , As)
r i gh tS i d e <− log (FRR)
output <− apply (vpmA, 1 , f i ndDi f f e r enc eGene ra l ,FRR=FRR) #
output [ 1 ]
index <− which .min(abs ( output−r i gh tS i d e ) )
i f ( plotAndPrint==T){
plot ( r i gh tS ide−output~sequence [ , 1 ] , yl im=c (min(0 ,min(
r i gh tS ide−output ) ) ,max( r i gh tS ide−output ) ) , type = " l "
, xlab=" value ␣ o f ␣v" , ylab="S^2∗FRR−output" )
abline ( a=0,b=0,col=1, l t y =2)
print (paste ( "v : ␣" ,vpmA[ index , 1 ] , "p : ␣" ,vpmA[ index , 2 ] , "␣m:
␣" ,vpmA[ index , 3 ] , "␣A: ␣" ,vpmA[ index , 4 ] ) )
print ( sOfT (vpmA[ index , ] ) )
}
i f ( comPois | | invGaus | | Hougaard ) {
v <− vpmA[ index , 1 ] ; p <− vpmA[ index , 2 ] ; m <− vpmA[
index , 3 ]
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causa lRat io <− as .numeric ( returnCausa lRisk (HRobs=
observedHR , A=As [ index ] , v=v , m=m) )
return ( causa lRat io [which( causa lRat io > 0) ] )
}
else return (paste ( "The␣v␣ value ␣ i s : ␣" ,vpmA[ index , 1 ] , " , ␣with
␣ d i f f e r e n c e " , r i gh tS ide−output [ index ] ) )
}
f indInver s eGauss i anRat io <− function (FRR, S , to1=20, l en =1000 ,
r r =2.10 , observedHR=1.23) {
m <− −0.5
rightHand <− 2
sequence <− cbind ( sequence1 , p , rep (m, length ( sequence1 ) ) )
}
#findInverseGauss ianV <− f unc t i on ( v ,A)
#f indAgenera l H_0 ( which i s denoted A in the func t i on ) ,
g i ven data on \nu , \ rho and m
f indAgenera l <−function (S ,vpm) {
v <− vpm [ 1 ] ; p = vpm [ 2 ] ; m = vpm [ 3 ]
u <− ( log (S)/p +1)^(1/m)
A <− (v−u∗v )/u
return (A)
}
#f indDi f f e r enceGenera l i s used to f i nd the minimal \nu in
f indVgenera l
f i ndD i f f e r en c eGene r a l <− function ( inputVector ,FRR) {
v <− as . vector ( inputVector ) [ 1 ] ; p <− as . vector ( inputVector
) [ 2 ] ; m <− as . vector ( inputVector ) [ 3 ] ; A <− as . vector (
inputVector ) [ 4 ]
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return (p∗(1−2∗( v/ ( v+A) )^m + (v/ ( v+2∗A) )^m ) )
}
#ri s kRa t i o6 .15 i s de r i v ed from formula 6.15 in Aalen e t a l ,
Su r v i v a l and Event h i s t o r y ana l y s i s
r i s kRat i o6 .15<− function (p ,m, v ,A, r ) {
nominator <− r ∗ (1 + A / v ) ^(m + 1)
denominator <− (1 + r∗A / v ) ^(m + 1)
return ( nominator/denominator )
}
#returnCausa lRisk i s used to numer ica l l y f i nd the causa l
hazard ra t i o , g i ven r_obs (HRobs)
returnCausa lRisk <− function (HRobs , A, v ,m=0){
r=NA
i f (m==0){
r <− HRobs / (1 + A/v − HRobs∗A/v )
} else i f (m==−0.5){
r <− polyroot (c(−HRobs^2,−HRobs^2∗A/v,1+A/v ) )
} else r <− tryCatch ({
uniroot ( HRcausalFunction , i n t e r v a l=c ( 0 , 6 ) , HRobs=HRobs ,
A=A, v=v , m=m) [ 1 ]
} , warning = function (war ) {
print ( "warning ! ! ! " )
return (0 )
} , e r r o r = function ( e r r ) {
print ( " e r r o r ! ! ! " )
return (0 )
}
)
#r <− HRobs^(1/(m+1)) / (1 + A/v − HRobs^(1/(m+1))∗A/v )
return ( r )
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}#returnCausa lRisk i s used to numer ica l l y f i nd the causa l
hazard ra t i o , g i ven r_obs (HRobs)
#This i s e xp re s s i on (13)
returnObservedRisk <− function ( r , A, v ,m=0){
HRobs <− r ∗ ( (1 + A/v ) / (1 + r∗A/v ) ) ^ (m + 1)
return (HRobs)
}
#HRcausalFunction i s used in f indVgenera l to numer ica l l y
f i nd the causa l hazard ra t i o , g i ven r_obs (HRobs)
HRcausalFunction <− function ( r , HRobs , A, v , m) {
equationHR <− HRobs^(1/ (m+1) )∗(1 + A∗r/v ) − r ^(1/ (m+1) )∗
(1+A/v )
return ( equationHR )
}
#Finding the FRR ov Y=1, g iven data on Y=0 ( f o r f i g u r e 2)
f r rEventFunct ion <− function (S , FRR) {
(FRR∗(1−2∗S+S^2)−1+2∗S)/S^2
}
# Veryfy ing t ha t the code i s OK
sOfT <− function (vpmA){
v = vpmA [ 1 ] ; p = vpmA [ 2 ] ; m = vpmA [ 3 ] ; A = vpmA[ 4 ]
withinLog <− −p∗(1−(v/ ( v + A) )^m)
return (exp( withinLog ) )
}
# We can now de r i v e numeric con f idence i n t e r v a l s by
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s imu l a t i on s .
# Let k denote the number o f con f idence i n t e r v a l s .
numericCIgamma <− function ( HRobsDerived=resultsNaiveCoxph ,
RiskDerived=estimatedPropGeneral , FRRderived=
r i s kRa t i o I n t e r v a l ) {
iLogHRobs <− rnorm(1 ,mean = log ( HRobsDerived [ 1 ] ) , sd = (
log ( HRobsDerived [ 1 ] ) − log ( HRobsDerived [ 2 ] ) )/qnorm
( 0 . 9 75 ) )
iS <− rnorm(1 ,mean = RiskDerived [ 1 ] , sd= abs ( RiskDerived
[1]−RiskDerived [ 2 ] ) /qnorm( 0 . 9 75 ) )
iLogFRR <− rnorm(1 ,mean = log ( FRRderived [ 1 ] ) , sd= ( log (
FRRderived [ 1 ] )−log ( FRRderived [ 2 ] ) )/qnorm( 0 . 9 75 ) )
output <− f indV (S=iS ,FRR=exp( iLogFRR) , observedHR=exp(
iLogHRobs ) , nonStandard = T, printV=F)
return ( output )
}
numericCIpvf <− function ( HRobsDerived=resultsNaiveCoxph ,
RiskDerived=estimatedPropGeneral , FRRderived=
r i s kRa t i o I n t e r va l , invGausIn=F, gamDistIn=F, comPoisIn=F,
HougaardIn=F, nonSuscepIn=0.01 ,mHougaardIn=−0.25 , r r I n
=2.10) {
iLogHRobs <− rnorm(1 ,mean = log ( HRobsDerived [ 1 ] ) , sd = (
log ( HRobsDerived [ 1 ] ) − log ( HRobsDerived [ 2 ] ) )/qnorm
( 0 . 9 75 ) )
iS <− rnorm(1 ,mean = RiskDerived [ 1 ] , sd= abs ( RiskDerived
[1]−RiskDerived [ 2 ] ) /qnorm( 0 . 9 75 ) )
iLogFRR <− rnorm(1 ,mean = log ( FRRderived [ 1 ] ) , sd= ( log (
FRRderived [ 1 ] )−log ( FRRderived [ 2 ] ) )/qnorm( 0 . 9 75 ) )
output <− f indVgenera l (S=iS ,FRR=exp( iLogFRR) , observedHR=
exp( iLogHRobs ) , invGaus=invGausIn , gamDist=gamDistIn ,
comPois=comPoisIn , Hougaard=HougaardIn , nonSuscep=
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nonSuscepIn , mHougaard=mHougaardIn , r r=r r In )
return ( output )
}
######## Functions f i n i s h e d #################
######## Numeric c a l c u l a t i o n s f o l l o w s #######
# Der iva t ion o f con f idence i n t e r v a l s :
# Since r i s a monotone func t i on o f r_obs ( emp i r i c a l l y
j u s t i f i e d by p l o t s ) ,
# we p lug in the bounds o f r_obs and s o l v e exp re s s i on (10)
#robs = 1 . 5 ; s u r v i v i n g = 0.9 s t
robs = 1 . 2 ; su rv i v i ng = 0 .5
###### Exp l i c i t c a l c u l a t i o n s ################
#Figure 2
FRRs <− seq ( from=1.11 , to=5, length . out=501)
FRRs1s <− sapply (FRRs, frrEventFunct ion , S=su rv i v i ng )
FRRs1s <− seq ( from=1.03 , to =1.4 , length . out=501)
est im <− sapply (FRRs1s , findV , S=surv iv ing , observedHR=robs )
est im2 <− sapply (FRRs1s , f indVgenera l , S=surv iv ing , invGaus = T
, observedHR=robs )
est im3 <− sapply (FRRs1s , f indVgenera l , S=surv iv ing , Hougaard =
T,mHougaard = −0.125 , observedHR=robs )
est im4 <− sapply (FRRs1s , f indVgenera l , S=surv iv ing , comPois=T,
nonSuscep = 0 .01 , observedHR=robs )
#p l o t ( est im~FRRs, type=" l " , y l a b="Hazard r a t i o " , x l a b="Fami l i a l
Re l a t i v e Risk (FRR) " , y l im=c (1 ,5) , x l im=c (1 ,5) )
#ab l i n e (a=1.5 , b=0, l t y =2)
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plot ( est im~FRRs1s , type=" l " , ylab="Hazard␣ r a t i o " , xlab="Twin␣
Re la t i v e ␣Risk␣ (TRR)" , ylim=c ( 1 , 3 ) , xl im=c ( 1 . 1 , 1 . 4 ) )
abline ( a=1.2 ,b=0, l t y =2)
l ines (FRRs1s , estim2 , col=2)
l ines (FRRs1s , estim3 , col=3)
l ines (FRRs1s , estim4 , col=4)
legend ( x=" t o p l e f t " ,c ( expression ( ’HR’ [ cau ]∗ ’ (90) , ␣compound␣
Poisson ’ ) , expression ( ’HR’ [ cau ]∗ ’ (90) , ␣Gamma ’ ) , expression (
’HR’ [ cau ]∗ ’ (90) , ␣Hougaard ’ ) , expression ( ’HR’ [ cau ]∗ ’ (90) , ␣
i nv e r s e ␣Gaussian ’ ) , expression ( ’HR’ [MR]∗ ’ (90) ’ ) ) , l t y=c
( 1 , 1 , 1 , 1 , 2 ) , col=c ( 4 , 1 , 3 , 2 , 1 ) , cex =1.25)
### New Sec t ion − see how b i a s v a r i e s wi th f o l l ow up time .
#Let the ra t e be cons tant a lpha
propAl ive <− seq ( from=1, to=0, length . out = 1001)
#Assume d i s t r i u b t i o n s wi th var=1
r In =1.2
gammaVpm <− c (1 ,1 e9 , 1/1e9 ) ; invGausVpm <− c (0.5 ,−1 ,−0.5) ;
hougaardVpm <− c (−0.125+1 ,(−0.125+1)/−0.125 ,−0.125) ;
compPoissonVpm <−c (1/(−log ( 0 . 1 )−1)+1, −log ( 0 . 1 ) , 1/(−log
( 0 . 1 )−1) )
cumHazardsGamma <− f indAgenera l ( propAlive ,gammaVpm)
cumHazardsInvGaus <− f indAgenera l ( propAlive , invGausVpm)
cumHazardsHougaard <− f indAgenera l ( propAlive , hougaardVpm)
cumHazardsCompPois <− f indAgenera l ( propAlive , compPoissonVpm)
observedRisksGamma <− sapply (cumHazardsGamma ,
returnObservedRisk , r=rIn , v=gammaVpm[ 1 ] , m=gammaVpm[ 3 ] )
observedInvGaus <− sapply ( cumHazardsInvGaus ,
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returnObservedRisk , r=rIn , v=invGausVpm [ 1 ] , m=invGausVpm
[ 3 ] )
observedHougaard <− sapply ( cumHazardsHougaard ,
returnObservedRisk , r=rIn , hougaardVpm [ 1 ] , m=hougaardVpm
[ 3 ] )
observedCompPois <− sapply ( cumHazardsCompPois ,
returnObservedRisk , r=rIn , compPoissonVpm [ 1 ] , m=
compPoissonVpm [ 3 ] )
plot ( observedRisksGamma~propAlive , xl im=c ( 1 , 0 ) , yl im=c
( 0 . 7 , 1 . 3 ) , type=" l " , xlab="Proport ion ␣ a l i v e " , ylab = "
Unadjusted␣hazard␣ r a t i o " , l t y =2)
l ines ( observedInvGaus ~ propAlive , l t y =2, col=2)
l ines ( observedHougaard ~ propAlive , l t y =2, col=3)
l ines ( observedCompPois ~ propAlive , l t y =2, col=4)
abline ( a=rIn , b=0, l t y =1)
legend ( x=" bot tomle f t " ,c ( expression ( ’HR’ [ obs ]∗ ’ (90) , ␣compound
␣Poisson ’ ) , expression ( ’HR’ [ obs ]∗ ’ (90) , ␣Gamma ’ ) , expression
( ’HR’ [ obs ]∗ ’ (90) , ␣Hougaard ’ ) , expression ( ’HR’ [ obs ]∗ ’ (90) , ␣
i nv e r s e ␣Gaussian ’ ) , expression ( ’HR’ [ cau ]∗ ’ (90) ’ ) ) , l t y=c
( 2 , 2 , 2 , 2 , 1 ) , col=c ( 4 , 1 , 3 , 2 , 1 ) , cex =1.25)
returnObservedRisk ( r , A, v ,m=0)
#Example on Alcoho l and a l l cause mor ta l i t y , Sec t ion 4
f r rAu s s i e <− 1 .27
sAuss i e <− 0 .56
obsAuss ie <− 0 . 6 8 ; lowerAuss i e <− 0 . 5 4 ; upperAussie <− 0 .87
#Resu l t s in Sec t ion 4.1
aus s i eEs t imate s <− c ( obsAussie , lowerAuss ie , upperAussie ) #
auss i eEs t imate s <− c ( 3 . 0 , 2 . 0 , 4 . 0 )
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f indVgenera l (FRR = fr rAus s i e , S=sAuss ie , observedHR =
lowerAuss ie , invGaus = T)
aussieGamma <− sapply ( auss i eEst imates , findV ,FRR = f r rAus s i e ,
S=sAuss ie , nonStandard = T, printV=T)
auss ieInvGaus <− sapply ( auss i eEst imates , f indVgenera l , S=
sAuss ie ,FRR=f r rAus s i e , invGaus = T, plotAndPrint = T, to1
=1)
auss ieHougaard <− sapply ( auss i eEst imates , f indVgenera l , S=
sAuss ie ,FRR=f r rAus s i e , Hougaard = T,mHougaard = −0.125 ,
plotAndPrint=T, to1=1)
aussieCPound <− sapply ( auss i eEst imates , f indVgenera l , S=
sAuss ie ,FRR=f r rAus s i e , comPois=T, nonSuscep = 0 .10 ,
plotAndPrint=T)
#Find numeric con f idence i n t e r v a l s .
set . seed (1 )
CIalmeidaExample <− r e p l i c a t e (n=2e3 , numericCIgamma(
HRobsDerived=c ( 0 . 6 8 , 0 . 5 4 , 0 . 8 7 ) , RiskDerived=c
( 0 . 5 6 , 0 . 5 6 , 0 . 5 6 ) , FRRderived=c ( 1 . 2 7 , 1 . 2 0 , 1 . 3 4 ) ) )
quantile ( CIalmeidaExample , c ( 0 . 0 2 5 , 0 . 5 , 0 . 9 7 5 ) )
CIalmeidaExampleInvGau <− r e p l i c a t e (n=2e3 , numericCIpvf (
HRobsDerived=c ( 0 . 6 8 , 0 . 5 4 , 0 . 8 7 ) , RiskDerived=c
( 0 . 5 6 , 0 . 5 6 , 0 . 5 6 ) , FRRderived=c ( 1 . 2 7 , 1 . 2 0 , 1 . 3 4 ) , invGausIn=T
) )
quantile ( CIalmeidaExampleInvGau , c ( 0 . 0 2 5 , 0 . 5 , 0 . 9 7 5 ) )
CIalmeidaExampleComPois <− r e p l i c a t e (n=2e3 , numericCIpvf (
HRobsDerived=c ( 0 . 6 8 , 0 . 5 4 , 0 . 8 7 ) , RiskDerived=c
( 0 . 5 6 , 0 . 5 6 , 0 . 5 6 ) , FRRderived=c ( 1 . 2 7 , 1 . 2 0 , 1 . 3 4 ) , comPoisIn =
T, nonSuscepIn = 0.10 ) )
quantile ( CIalmeidaExampleComPois , c ( 0 . 0 2 5 , 0 . 5 , 0 . 9 7 5 ) )
CIalmeidaExampleHougaard <− r e p l i c a t e (n=2e3 , numericCIpvf (
HRobsDerived=c ( 0 . 6 8 , 0 . 5 4 , 0 . 8 7 ) , RiskDerived=c
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( 0 . 5 6 , 0 . 5 6 , 0 . 5 6 ) , FRRderived=c ( 1 . 2 7 , 1 . 2 0 , 1 . 3 4 ) , HougaardIn
= T,m = −0.125 ) )
quantile ( CIalmeidaExampleHougaard , c ( 0 . 0 2 5 , 0 . 5 , 0 . 9 7 5 ) )
#Resu l t s in Sec t ion 4 . 1 . 1
exp( log ( 0 . 6 8 ) / (−0.172∗14 . 2 ) ) #Per un i t per week . Observed
######## Ca l cu l a t i on s f i n i s h e d ##################
######## The next s e c t i on d e s c r i b e s s imu la t i on s #
######## New func t i on s are introduced , and ######
######## and the former f unc t i on s w i l l a l s o #####
######## be used . ###############################
l ibrary ( s u r v i v a l )
l ibrary ( e p i t o o l s )
# We w i l l now show how s imu la t i on s can be used to v e r i f y the
approach .
# n number o f i n d i v i d ua l s , h0 i s b a s e l i n e hazard
# nu i s parameter o f gamma, t1 time at f o l l ow up
# Assume tha t we observe i n d i v i d u a l s u n t i l t ime t1=50 years .
Who su r v i v e ?
# Let the HR in the exposed i n d i v i d u a l s be 0 .8
# Among the surv i vo r s , we can now es t imate the su r v i v o r
t imes . Let H( t ) = ht .
# The inv e r s e i s H−1(H( t ) ) = H( t )/h = t . I . e . an Exponent ia l
d i s t r i b u t i o n .
# We w i l l now s imu la t e the hazard func t i on
sampleSurvivalTime <− function (u , h0 , r=1){
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uni <− runif (1 )
out <− − log ( uni ) / ( h0∗u∗r )
return ( out )
}
# Let us assume a Gamma d i s t r i b u t e d f r a i l t y
# Let the ra t e=nu such t ha t t1 i s the time to s t a r t f o l l ow
up
# and tFo l l ow i s the number o f years under f o l l ow up time
getConfidenceIntervalGamma <− function (n=1e6 , h0=0.002 , nu=1
/9 ,HRcau=0.8 , t1=50, tFol low = 2) {
uExp <− rgamma(n , shape=nu , scale = 1/nu )
uUnexp <− rgamma(n , shape=nu , scale = 1/nu )
#Sample s u r v i v a l t imes
timesExp <− sapply (uExp , sampleSurvivalTime , h0=h0 , r=
HRcau) #summary( timesExp )
timesUnexp <− sapply (uUnexp , sampleSurvivalTime , h0=h0 , r
=1) #summary( timesUnexp )
# Se l e c t those i n d i v i d u a l s who have s u r v i v a l t imes l a r g e r
than t1
survivorsTimesExp <− timesExp [ timesExp > t1 ] − t1
survivorsTimesUnexp <− timesUnexp [ timesUnexp > t1 ] − t1
eventsExp <− survivorsTimesExp < tFol low
eventsUnexp <− survivorsTimesUnexp < tFol low
modifsurvivorsTimesExp <− survivorsTimesExp ;
modifsurvivorsTimesExp [ modifsurvivorsTimesExp >
tFol low ] <− tFol low
modifsurvivorsTimesUnexp <− survivorsTimesUnexp ;
modifsurvivorsTimesUnexp [ modifsurvivorsTimesUnexp >
tFol low ] <− tFol low
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# Make input ready f o r the coxph model
exposu r e Ind i ca to r <− c ( rep (1 , length ( modifsurvivorsTimesExp
) ) , rep (0 , length ( modifsurvivorsTimesUnexp ) ) )
s t a t u s e s <− c ( eventsExp , eventsUnexp )
t imes <− c ( modifsurvivorsTimesExp ,
modifsurvivorsTimesUnexp )
# Let us f i t a Cox model
naiveCoxph <− coxph ( Surv ( times , s t a t u s e s ) ~
exposu r e Ind i ca to r )
resultsNaiveCoxph <− (summary( naiveCoxph )$conf . i n t ) [ c
( 1 , 3 , 4 ) ]
# Firs t , assume t ha t the s u r v i v a l i s known . Then we s imply
use Express ion 5 to f i nd S
St1 <− (nu/ (nu+h0∗t1 ) )^nu
# Furthermore , we use expre s s i on 8 to f i nd the FRR( t1 )
FRRt1 <− (nu/ (nu+2∗h0∗t1 ) )^nu / St1^2
# Then we use the f unc t i on s to f i nd the observed va lue
adjustedCoxph <− f indV (S=St1 ,FRR=FRRt1 , observedHR=
resultsNaiveCoxph , nonStandard = T, printV=F)
#This l o o k s very good . . . . !
return ( rbind ( resultsNaiveCoxph , adjustedCoxph ) )
}
# Now, assume tha t S and FRR are only known with unce r t a in t y
# Assume tha t we ob ta ined n1 unexposed twin pa i r s from the
same popu la t i on wi th Us .
f indExpectedSurv iva l <− function (h , t , u , hr=1){
H <− h∗t
return (exp(−H∗u∗hr ) )
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}# Function to f i nd the expec ted s u r v i v a l u n t i l t ime t1
getCIgenera lPopu lat ion<− function ( n1In=n1 , nuIn=nu , h0In=h0 ,
t In=t1 , hrIn=HRcau) {
uGeneralPopulat ion <− rgamma( n1In , shape=nuIn , scale = 1/
nuIn )
probSurvivalGP <− f indExpectedSurv iva l ( h0In , t=tIn , hr=1,u=
uGeneralPopulat ion ) # Rather than hr=hrIn
survivorsGP <− sapply ( probSurvivalGP , rbinom , n=1, s i z e =1)
propGP <− prop . t e s t ( table ( survivorsGP ) )
estimatedPropGP <− 1−c (propGP$est imate , propGP$conf . i n t ) [ c
( 1 , 3 , 2 ) ]
return ( estimatedPropGP )
}
# Function to f i nd the twin recurrence r i s k
getCItwinRecurrenceRisk <− function ( n1In=n1 , nuIn=nu , h0In=h0
, t In=t1 , hrIn=HRcau) {
uTwinPairs <− rgamma( n1In , shape=nuIn , scale = 1/nuIn )
probSurv iva l <− f indExpectedSurv iva l ( h0In , t=tIn , hr=1,u=
uTwinPairs ) # ra the r than hr=hrIn
surv ivorsTwinPai r s <− cbind ( sapply ( probSurvival , rbinom , n
=1, s i z e =1) , sapply ( probSurvival , rbinom , n=1, s i z e =1) )
su rv i vo r sCond i t i ona l <− surv ivorsTwinPai r s [
surv ivorsTwinPai r s [ ,1 ]==1 ,2 ]
# For a s t r a i g h t f o rwa r d approach , l e t us use the f i r s t
column fo r the e s t ima t i on o f the Su r v i v a l .
# Find the propor t ion o f su c c e s s e s
genera lProb <− prop . t e s t ( table ( surv ivorsTwinPai r s [ , 1 ] ) )
est imatedPropGeneral <− 1−c ( genera lProb$est imate ,
genera lProb$conf . i n t ) [ c ( 1 , 3 , 2 ) ]
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cond i t i ona lProb <− prop . t e s t ( table ( su rv i vo r sCond i t i ona l ) )
est imatedProbCondit iona l <− 1−c ( cond i t i ona lProb$est imate ,
cond i t i ona lProb$conf . i n t ) [ c ( 1 , 3 , 2 ) ]
tab leMatr ix <− as . table ( rbind ( table ( surv ivorsTwinPai r s
[ , 1 ] ) , table ( su rv i vo r sCond i t i ona l ) ) )
r i s kRa t i o I n t e r v a l <− r i s k r a t i o . wald ( tab leMatr ix )$measure
[ 2 , ]
return ( r i s kRa t i o I n t e r v a l )
}
# To check i f the con f idence i n t e r v a l i s correc t , we repea t
c a l c u l a t i o n s o f the observed HR, the FRR and the Su r v i v a l
p r o b a b i l i t y
checkCI i sCorrec t <− function ( nInput=1e4 , nInputTwin=1e4 ,
h0Input =0.002 , nuInput=1/9 ,HRcauInput=0.8 , t1Input=50,
tFol lowInput = 1 , k=1e4 ) {
CIHRobserved <− getConfidenceIntervalGamma (n=nInput , h0=
h0Input , nu=nuInput ,HRcau=HRcauInput , t1=t1Input , tFol low
= tFol lowInput )
CIriskGP <− getCIgenera lPopu lat ion ( n1In=nInput , nuIn=
nuInput , h0In=h0Input , t In=t1Input , hrIn=HRcauInput )
CIriskTwins <− getCItwinRecurrenceRisk ( n1In=nInputTwin ,
nuIn=nuInput , h0In=h0Input , t In=t1Input , hrIn=HRcauInput )
#pr in t (CIHRobserved [ 1 , ] )
#pr i n t ( CIriskGP )
#pr in t ( CIriskTwins )
totalDraw <− r e p l i c a t e (n=k , numericCIgamma(HRobsDerived=
CIHRobserved [ 1 , ] , RiskDerived=CIriskGP , FRRderived=
CIriskTwins ) )
CI to ta l <− round( quantile ( totalDraw , c ( 0 . 0 2 5 , 0 . 5 , 0 . 975 ) )
,2 )
return (c ( CItota l , CIHRobserved [ 1 , ] ) )
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}######## Exp l i c i t input to s imu la t i on s ####
set . seed (123)
output1st123 <− r e p l i c a t e (n=5e2 , checkCI i sCorrec t ( ) )
# Check how many CI t ha t cover the t rue va lue :
#outpu t1s t123 <− ge t ( load ("/Users/mat s j u l i u s s t en s rud/
Documents/NEJM/data/simDataEpiMethods1version2 . RData") )
s t r ( output1st123 )
sum( output1st123 [ 1 , ] < 0 .8 & output1st123 [ 3 , ] > 0 . 8 )
Toutput1st123 <− t ( output1st123 )
coverage1stAdjusted <− 1−sum( Toutput1st123 [ , 1 ] > 0 .80 |
Toutput1st123 [ , 3 ] < 0 . 80 ) / 500 # Of these , 0.092
coverage . 0.91
coverage1stMar <− 1−sum( Toutput1st123 [ , 5 ] > 0 .80 |
Toutput1st123 [ , 6 ] < 0 . 80 ) / 500 # Of these , a l l o f the
i n t e r v a l s are above
summary( Toutput1st123 [ , 2 ] )
summary( Toutput1st123 [ , 4 ] )
set . seed (123)
output2nd123 <− r e p l i c a t e (n=5e2 , checkCI i sCorrec t ( nInput=1e6 ,
h0Input =0.003 , nuInput=1/15 ,HRcauInput=0.7 , t1Input=50,
tFol lowInput = 1 , k=1e5 ) )
sum( output2nd123 [ 1 , ] < 0 .7 & output2nd123 [ 3 , ] > 0 . 7 )
summary( output2nd123 [ 2 , ] )
Toutput2nd123 <− t ( output2nd123 )
coverage2ndAdjusted <− 1−sum( Toutput2nd123 [ , 1 ] > 0 .70 |
Toutput2nd123 [ , 3 ] < 0 . 70 ) / 500 . # Of these , 0.092
coverage . 0.91
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coverage2ndMar <− 1−sum( Toutput2nd123 [ , 5 ] > 0 .70 |
Toutput2nd123 [ , 6 ] < 0 . 70 ) / 500 . # Of these , a l l o f the
i n t e r v a l s are above
summary( Toutput2nd123 [ , 2 ] )
summary( Toutput2nd123 [ , 4 ] )
set . seed (123)
output3rd123 <− r e p l i c a t e (n=5e2 , checkCI i sCorrec t ( nInput=1e6 ,
h0Input =0.030 , nuInput=1/5 ,HRcauInput=0.7 , t1Input=50,
tFol lowInput = 1 , k=1e5 ) )
Toutput3rd123 <− t ( output3rd123 )
coverage3rdAdjusted <− 1−sum( Toutput3rd123 [ , 1 ] > 0 .70 |
Toutput3rd123 [ , 3 ] < 0 . 70 ) / 500 . # Of these , 0.092
coverage . 0.91
coverage3rddMar <− 1−sum( Toutput3rd123 [ , 5 ] > 0 .70 |
Toutput3rd123 [ , 6 ] < 0 . 70 ) / 500 . # Of these , a l l o f the
i n t e r v a l s are above
summary( Toutput3rd123 [ , 2 ] )
summary( Toutput3rd123 [ , 4 ] )
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Figure 1: Directed acyclic graph (DAG) of a simple scenario which may involve
survival bias. X denotes an exposure, S denotes survival until a particular time
point, Y is the outcome of interest and U is an unmeasured confounder.
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Figure 2: Hazard ratios plotted as a function of the proportion alive at t0. The casual
hazard ratio is HRcau(t) = 1.2 (solid line). The dashed lines show HRobs(t = t1),
where assuming different frailty distributions: Gamma distribution (black), inverse
Gaussian distribution (red), Hougaard distribution (green) and compound Poisson
distribution (blue).
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Figure 3: Hazard ratios plotted as a function of the TRR. We have assumed that
the marginal hazard ratio conditional on survival is rmar(t = t1) = 1.2 (dashed line).
The solid lines show HRcau(t = t1), i.e. the causal hazard ratio conditioning on U ,
assuming a gamma distribution (black), an inverse Gaussian distribution (red), a
Hougaard distribution (green) and a compound Poisson distribution (blue).
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Figure 4: Causal graph of a Mendelian Randomisation study with loss to follow-
up. Here, G is the genetic instrument, A denotes an exposure, S denotes survival
until a particular time point, Y is the outcome of interest and U is an unmeasured
confounder.
54
